China SXT Pharmaceuticals, Inc.
SXTC
$2.29
$0.7144.94%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 91.72% | 91.72% | 248.59% | 248.59% | -548.75% |
| Total Depreciation and Amortization | -33.27% | -33.27% | -28.39% | -28.39% | -6.55% |
| Total Amortization of Deferred Charges | -58.46% | -58.46% | 233.33% | 233.33% | -31.71% |
| Total Other Non-Cash Items | -99.59% | -99.59% | -307.79% | -307.79% | 2,961.11% |
| Change in Net Operating Assets | -336.35% | -336.35% | -159.66% | -159.66% | 28.06% |
| Cash from Operations | -134.16% | -134.16% | -387.87% | -387.87% | -5.54% |
| Capital Expenditure | -- | -- | 86.17% | 86.17% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1,480.00% | 1,480.00% | -67.00% |
| Cash from Investing | 107.14% | 107.14% | 113.18% | 113.18% | -50.25% |
| Total Debt Issued | 5,815.87% | 5,815.87% | -65.95% | -65.95% | -- |
| Total Debt Repaid | 98.30% | 98.30% | -93.00% | -93.00% | 58.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 74.43% | 74.43% | -- |
| Cash from Financing | 262.20% | 262.20% | -86.89% | -86.89% | 59.69% |
| Foreign Exchange rate Adjustments | 158.40% | 158.40% | 390.05% | 390.05% | 12.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.02% | 209.02% | -95.74% | -95.74% | 53.11% |